Korro Bio Stock (NASDAQ:KRRO), Quotes and News Summary

Q: What sector and industry does Korro Bio (KRRO) operate in?

Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Korro Bio Stock (NASDAQ: KRRO) stock price, news, charts, stock research, profile.

Open	$58.440
Close	$62.930
Volume / Avg.	28.094K / 32.385K
Day Range	57.180 - 63.300
52 Wk Range	14.000 - 97.910
Market Cap	$584.086M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	1.54%
Days to Cover	2.26

Recent News

Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.

Avi Kapoor

Why Newly Listed Korro Bio Shares Are Gaining Today

H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on editing ribonucleic acid (RNA) to treat various diseases.

Vandana Singh

Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Korro Bio Inc.

Sector

Health Care

Industry

Biotechnology

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Korro Bio (KRRO) stock?

You can purchase shares of Korro Bio (NASDAQ: KRRO) through any online brokerage.

View our list of the best stock brokerages.

Who are Korro Bio's (KRRO) competitors?

Other companies in Korro Bio’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Altimmune (NASDAQ:ALT) and AnaptysBio (NASDAQ:ANAB).

What is the target price for Korro Bio (KRRO) stock?

The latest price target for Korro Bio (NASDAQ: KRRO) was reported by HC Wainwright & Co. on Thursday, March 28, 2024. The analyst firm set a price target for 115.00 expecting KRRO to rise to within 12 months (a possible 82.57% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Korro Bio (KRRO)?

The stock price for Korro Bio (NASDAQ: KRRO) is $62.99 last updated April 25, 2024 at 7:00 AM EDT.

Does Korro Bio (KRRO) pay a dividend?

There are no upcoming dividends for Korro Bio.

When is Korro Bio (NASDAQ:KRRO) reporting earnings?

Korro Bio’s Q1 earnings are confirmed for Monday, May 27, 2024.

Is Korro Bio (KRRO) going to split?

There is no upcoming split for Korro Bio.

What sector and industry does Korro Bio (KRRO) operate in?

Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-